EUDA Health Holdings (EUDA) Research & Development (2022 - 2023)
EUDA Health Holdings' (EUDA) quarterly Research & Development came in at -$27299.0 in Q2 2023, down 104.21% year-on-year from $647854.0 in Q2 2022, and down 106.74% on a QoQ basis from $404771.0 in Q1 2023.
EUDA Health Holdings (EUDA) Research & Development (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has 2 years of Research & Development data on file, last reported at -$27299.0 in Q2 2023.
- On a quarterly basis, Research & Development fell 104.21% year-over-year to -$27299.0 in Q2 2023; TTM through Jun 2023 was $1.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.3 million, up 888.54% from the prior year.
- Research & Development for Q2 2023 stood at -$27299.0, down from $404771.0 in the prior quarter.
- Over the last five years, Research & Development for EUDA reached as high as $647854.0 in Q2 2022 and fell as low as -$27299.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Colliers International | 4,798.15 Bn | 4,797.86 Bn | - | - |
| 2 | IHS Holding | 60.96 Bn | 61.13 Bn | 231.80 | - |
| 3 | KE Holdings | 53.48 Bn | 50.59 Bn | 661.06 Mn | -156.88 Mn |
| 4 | Cbre | 39.71 Bn | 39.92 Bn | 1.85 Bn | - |
| 5 | Jones Lang Lasalle | 14.96 Bn | 14.65 Bn | - | - |
| 6 | Costar | 11.08 Bn | 9.80 Bn | 701.00 Mn | 421.00 Mn |
| 7 | Compass | 7.92 Bn | 7.44 Bn | 2.31 Bn | 119.00 Mn |
| 8 | FirstService | 6.01 Bn | 6.28 Bn | 480.66 Mn | - |
| 9 | Opendoor Technologies | 3.69 Bn | 2.69 Bn | 72.00 Mn | 24.00 Mn |
| 10 | EUDA Health Holdings | 2.22 Mn | 1.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -27,299.00 |
| Mar 31, 2023 | 404,771.00 |
| Jun 30, 2022 | 647,854.00 |
| Mar 31, 2022 | 2,946.00 |